Liquid chromatography-tandem mass spectrometry method for the measurement of serum mevalonic acid: A novel marker of hydroxymethylglutaryl coenzyme A reductase inhibition by statins

Annals of Clinical Biochemistry

Volumn 48, Issue 3, 2011, Pages 223-232

  Waldron, Jenna ^a   Webster, Craig ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVALONOLACTONE;

ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ELECTROSPRAY; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MEVALONIC ACID; MIDDLE AGED; REFERENCE VALUES; TANDEM MASS SPECTROMETRY;

EID: 79956115044     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010182     Document Type: Article

References (13)

1. Burtis CA, Ashwood ER. Tietz Textbook of Clinical Chemistry. Philadelphia: WB Saunders Company, 1999
2. Saini GS, Wani TA, Gautam A, et al. Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect. J Lipid Res 2006;47:2340-5
3. Siperstein MD, Fagan VM. Feedback control of mevalonate synthesis by dietary cholesterol. J Biol Chem 1966;241:602-9
4. Abrar M, Martin PD. Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002;773:103-11
5. Blumenthal RS. Statins: effective antiatherosclerotic therapy. Am Heart J 2000;139:577-83
6. Popjak G, Boehm G, Parker TS, Edmond J, Edwards PA, Fogelman AM. Determination of mevalonate in blood plasma in man and rat. Mevalonate 'tolerance' tests in man. J Lipid Res 1979;20:716-28
7. Parker TS, McNamara DJ, Brown CD, et al. Plasma mevalonate as a measure of cholesterol synthesis in man. J Clin Invest 1984;74:795-804
8. Hiramatsu M, Hayashi A, Hidaka H, Ueshima H, Kanno T. Enzyme immunoassay of urinary mevalonic acid and its clinical application. Clin Chem 1998;44:2152-7
9. Siavoshian S, Simoneau C, Maugeais P, et al. Measurement of mevalonic acid in human urine by bench top gas chromatography-mass spectrometry. Clin Chim Acta 1995;243:129-36
10. Woollen BH, Holme PC, Northway WJ, Martin PD. Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 2001;760:179-84
11. Jemal M, Schuster A, Whigan DB. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Commun Mass Spectrom 2003;17:1723-34
12. Jessome LL, Volmer DA. Ion suppression: a major concern in mass spectrometry. LCGC N Am 2006;24:498-510
13. Walker V, Mills GA. Solid-phase extraction in clinical biochemistry. Ann Clin Biochem 2002;39:464-77